Additionally, hypoglycaemia (low blood sugar), though less common with GLP-1 agonists than with insulin or sulphonylureas, can cause irritability, confusion, and mood changes when it does occur, particularly in patients taking concurrent diabetes medications
This morning, Ro dropped what is now the lowest entry point for an FDA approved GLP-1
Most reported problems trace to dosing errors rather than the formulation itself which is exactly why your compounder and clinical monitoring matter so much
The clinical literature on GLP-1 medications initially worried me because so many studies showed significant lean mass losses alongside the fat reduction
These may include acetaminophen (Tylenol) and ibuprofen (Advil, Motrin)
On the other hand, LC supplementation in combination with CHO effectively elevated muscle TC after 12 [6] and 24 weeks [5]